AdipoSeeds is advancing the development of human adipose tissue-derived platelet-like cells (ASCL-PLC; development code: ADS-01) for the treatment of intractable skin ulcers.

An overview of the clinical trial for ADS-01 has now been published on the Japan Registry of Clinical Trials (jRCT) system. You can view the details at the following URL:

jRCT Number: jRCT2033260542

We are now proceeding with preparations to promptly begin enrollment of the first patient.

This clinical trial has been selected for the Japan Agency for Medical Research and Development (AMED) “Project to Strengthen the Drug Discovery Venture Ecosystem” (FY2024), and we are utilizing subsidies provided through this program.